key: cord-0268327-zmo9t3p6 authors: Chatterjee, Sujoy; Yabaji, Shivraj M.; Bhattacharya, Bidisha; Waligurski, Emily; Vallavoju, Nandini; Ray, Somak; Brown, Lauren E.; Beeler, Aaron B.; Ivanov, Alexander R.; Kobzik, Lester; Porco, John A.; Kramnik, Igor title: Channeling macrophage polarization via selective translation inhibition by rocaglates increases macrophage resistance to Mycobacterium tuberculosis date: 2020-08-31 journal: bioRxiv DOI: 10.1101/691808 sha: 1dfe844c7daf2ee70582628940f249fd58b3fd03 doc_id: 268327 cord_uid: zmo9t3p6 Macrophages contribute to host immunity and tissue homeostasis via alternative activation programs. M1-like macrophages control intracellular bacterial pathogens and tumor progression. In contrast, M2-like macrophages shape reparative microenvironments that can be conducive for pathogen survival or tumor growth. An imbalance of these macrophages phenotypes may perpetuate sites of chronic unresolved inflammation, such as infectious granulomas and solid tumors. We have found that plant-derived and synthetic rocaglates sensitize macrophages to low concentrations of the M1-inducing cytokine IFN-gamma and inhibit their responsiveness to IL-4, a prototypical activator of the M2-like phenotype. Treatement of primary macrophages with rocaglates increased their resilience to oxidative stress, stimulated autophagy and killing of intracellular mycobacteria. Thus, rocaglates represent a novel class of immunomodulators that can direct macrophage polarization towards the M1-like phenotype in complex microenvironments associated with hypofunction of type 1 and/or hyperactivation of type 2 immunity, e.g. chronic bacterial infections, allergies and, possibly, certain tumors. The increasing problem of infectious diseases caused by antibiotic-resistant bacteria has 44 intensified a search for novel therapeutic approaches. Among them are host-directed therapies 45 (HDT) aimed at either boosting immune-mediated bacterial control or reducing 46 immunopathology, broadly referred to as mechanisms of host resistance or disease tolerance, 47 respectively (1). Many intracellular bacterial pathogens reside in macrophages, the very cells of 48 innate immune system whose major function is to eliminate invading pathogens. This paradox is 49 enabled by macrophages' plasticity, which successful pathogens exploit to create cellular niches 50 for persistence and replication within inflamed tissue of susceptible hosts. To combat intracellular bacteria, macrophages activate cell autonomous defense 52 mechanisms, such as phagocytosis, production of highly toxic reactive oxygen and nitrogen 53 species, bactericidal peptides, as well as phagosome maturation and autophagy to deliver the 54 ingested pathogens to lysosomes for destruction. This pro-inflammatory type of macrophage 55 activation can be induced by microbial ligands and proinflammatory cytokines. It is broadly 56 referred to as "classical" or M1 type, although this definition encompasses an array of related, 57 but non-identical macrophage activation states. Individuals whose macrophages fail to respond 58 to IFNγ, the prototypical M1 polarizing signal, are extremely susceptible to infections caused by Although rocaglates are known as potent translation inhibitors, we found that in the 104 presence of IFNγ at concentrations as low as 0.1 U/ml, select rocaglates induced the 105 upregulation of IRF1 protein, a master regulator of IFNγ-activated pathways. In the present 106 study, we delineate mechanisms of the enhancement the M1 macrophage polarization by 107 active rocaglates, demonstrate that rocaglates also inhibit macrophage responsiveness to 108 CSF-1 and IL-4 and potentiate killing of virulent Mtb by primary macrophages. To delineate the relationship between translation inhibition and macrophage activation 116 by rocaglates, we screened a library of synthetic rocaglate derivatives. Out of 86 compounds, 117 twenty-three induced significant Irf1 mRNA upregulation in the presence of 0.2 U/ml of IFNγ. Next, we determined the translation inhibitory concentrations IC 50 of these compounds using the 119 293TR-FLuc translation reporter cell line (16). We observed a tight negative correlation (r = -120 0.6832) between the Irf1 mRNA induction and IC 50 of those compounds (Fig.1A , Suppl. Table 121 1) demonstrating mechanistic link between the translational inhibition and Irf1 co-stimulation 122 properties. To verify this relationship in primary macrophages, first we compared translation 123 inhibition activities of two structurally similar rocaglates CMLD010536 and CMLD010850 124 ( Fig.1B) in mouse bone marrow-derived macrophages (BMDM) using a puromycin 125 incorporation assay (Fig 1 C) we used a puromycin incorporation assay. Puromycin incorporation during a one-hour pulse 140 was determined after 3, 9 and 24 h of rocaglate treatment using western blot with puromycin-141 specific antibodies. The rocaglate treatment significantly reduced translation rates at all 142 timepoints in a dose-dependent manner ( Fig.2A) . However, the levels of ongoing translation 143 were similar at all of the timepoints demonstrating that translation inhibition was partial and 144 sustained over the time course of the rocaglate treatment. To identify proteins expressed in 145 BMDMs after 24 h of treatment with 100 nM of CMLD010536, we performed proteomic analysis 146 using mass spectrometry (Suppl. Table 2 ). The abundance of Sequestosome 1 (SQSTM1, aka 147 p62) protein was found to significantly increase. We confirmed the induction of p62 protein and 148 mRNA ( Fig.2 we tested whether p62 induction by CMLD010536 is mediated by stress-activated MAP kinases. The p38 inhibitor (SB203580 at 10 uM), added 30 min prior to treatment with 100 nM 156 CMLD010536, completely abrogated p62 mRNA upregulation. The effect of the JNK inhibitor 157 (SB600125) was less prominent, while ERK inhibition (U0126/PD98059) had no effect (Fig.2D ). The p38 MAPK inhibitor also abrogated the expression of another rocaglate-induced 159 inflammatory gene, Txnip (Suppl. Fig.1A) . The MAP kinase inhibitors displayed similar effects 160 on the p62 protein levels (Suppl. Fig.1B) . We also observed a dramatic downregulation of 161 another rocaglate-inducible mRNA, Ptgs2, by the p38 inhibitor (Suppl. Fig.1C ). Next, we studies. Therefore, we tested whether the synergistic effect of the rocaglate on IRF1 induction 206 was mediated via alternative mechanism(s) involving MAP kinase activation. There is an 207 emerging evidence that serine (Ser-727) phosphorylation of STAT1 by stress-activated MAP 208 kinases p38 and JNK mediates various stress responses (36) and may account for nearly 80% 209 of IFNγ-induced transcriptional activity. Indeed, CMLD010536 boosted the levels of IRF1 210 protein in the presence of IFNγ at concentrations as low as 0.05 and 0.1 U/ml, and this boosting 211 effect was abrogated by p38 inhibition (Fig.2J ). The p38 inhibitor also suppressed the Irf1 212 mRNA co-stimulation by the rocaglate (Suppl. Fig.3A ). In contrast to the rocaglate treatment, 213 low concentrations of IFNγ alone did not induce the p38 phosphorylation (Fig.2K ). Finally, we 214 found that the CMLD010536 treatment induced STAT1 Ser727 phosphorylation as early as 215 15 min, which was maintained for at least 4 hours (Fig.2L ). These data demonstrate that the p38 MAPK pathway activation by rocaglates plays a 217 central role in their synergy with IFNγ in macrophage activation. Importantly, this STAT1 218 modification does not increase DNA binding or nuclear translocation of STAT1 dimers (37-39). Indeed, treatment with active rocaglates alone induced no Irf1 mRNA upregulation(15) and 220 even suppressed the basal IRF1 protein expression (Fig.2J) . Furthermore, the p38 inhibition did CMLD010536, silvestrol and rocaglamide A, but not by CMLD010850 (Fig.3C ), which is a much 241 less potent translational inhibitor and does not inhibit translation at this concentration (Fig 1C) . The upregulation of the IL-4-inducible genes is mediated by the transcription factor 243 STAT6. Using electrophoretic mobility shift assay (EMSA) with a STAT6 consensus sequence 244 oligonucleotide probe, we determined that pretreatment with 30 and 100 nM of CMLD010536 245 prior to IL-4 stimulation inhibited STAT6 DNA binding (Fig.3D ). This effect was not associated 246 with a decrease in the total STAT6 protein levels ( Fig.3E , upper panel). However, nuclear 247 STAT6 protein was somewhat reduced (Fig.3E , lower panel). These observations suggested 248 that the suppression of the STAT6 DNA binding activity was a regulatory phenomenon that 249 could not be simply attributed to inhibition of the STAT6 protein translation. Therefore, we 250 sought to determine whether the suppressor activity was mediated by MAP kinases. The p38 251 inhibitor, however, did not restore the expression of Arg1 inhibited by CMLD10536 (Fig.3F ). Instead, we observed that the rocaglate treatment mimicked the inhibitory effect of the ERK 253 inhibitor U0126 on IL4-induced Arg1 mRNA expression (Fig.3G) . Indeed, the rocaglate 254 treatment completely abrogated the ERK1/2 phosphorylation in IL4-stimulated macrophages 255 without affecting the total ERK1/2 levels (Fig.3H ). Although it remains to be determined whether 256 rocaglates inhibit ERK activation directly, or block upstream activators of ERK, this finding is 257 consistent with the previously described role of ERK1/2 in the alternative macrophage 258 activation. One of the relevant direct rocaglate targets in this pathway could be Myc, whose 259 activity is necessary for M2-like macrophage polarization (40, 41) and whose translation was 260 shown to be selectively inhibited by rocaglates(42). Next, we wanted to determine whether the rocaglates treatment induces transient or increasing the CSF1-containing conditioned media 3-fold did not improve cell survival in the 309 presence of rocaglates. We also observed that ERK1/2 phosphorylation, which is downstream 310 of CSF1 receptor (CSF1R) signaling, could not be restored in the rocaglates-treated cells by 311 increasing CSF1 (Fig.4D ). Finally, we found that rocaglates suppressed the expression of CSF1 312 receptor (Fig.4E) . Therefore, we attempted to identify alternative survival factors and compared 313 the survival of the rocaglates-treated BMDMs in the presence of GM-CSF, IFNγ and IL-4 314 (Fig.4F) . Surprisingly, IL-4 significantly improved the the macrophage survival within 72 h, as 315 compared to GM-CSF and IFNγ. However, IL-4 did not restore macrophage proliferation in the 316 presence of the rocaglate (Suppl. Fig.5D ). The pro-survival effect of IL-4 on rocaglate-treated 317 BMDMs was not mediated by either STAT6 or ERK1/2, since both were inhibited by rocaglate in 318 the presence of IL-4 ( Fig.3D and 3H) . Possibly, this effect is mediated by activation of the Akt 319 pathway downstream of the IL-4 receptor(46). The pro-survival effect of IL-4 was also observed in Mtb-infected BMDM cultures at 72 h 321 p.i. (Fig.4G) . In contrast, GM-CSF failed to improve the macrophage survival in these settings 322 (Suppl. Fig.5C ). Therefore, we tested the effects of rocaglates on Mtb replication in 323 macrophages in the presence of IL-4. The bacterial loads were estimated using an optimized 324 quantitative PCR method developed in our laboratory (Yabaji et al., submitted for publication). We observed an approximately 2-fold increase between 0 -72 h p.i. in naïve macrophages 326 (Fig.4H ). Pretreatement with IL4 had no effect on the bacterial uptake. In the presence of IL-4, It is also noteworthy that biological outcomes of rocaglates on primary macrophages The canonical eIF4A-dependent translation inhibition by rocaglates may provide a 393 stress-like "conservation of resources" signal that leads to the inhibition of ERK phosphorylation 394 and, thus, to the coordinated downregulation of several anabolic pathways. Yet another 395 mechanism may be associated with a recently described alternative target of rocaglates - The above data suggest that rocaglates may represent a novel class of HDTs with 439 broad applications in vivo. Rocaglates are active against protozoan infections, such as 440 malaria (57) The rocaglates' ability to direct M1-like macrophage polarization also warrants their 456 evaluation in chronic non-infectious pathologies, where macrophages are exposed to complex, The correlation coefficient was calculated using GraphPad Prism 8. BMDMs were treated with 0.1 U/ml of IFNγ either in the absence or presence of the rocaglate 527 and phospho-p38 levels were determined by Western blot using phospho-p38 specific antibody. Puromycin labelling for measuring the intensity of translation was performed as described (67). In brief, 5 µg/ml puromycin (Sigma,) was added in the culture medium and incubated for 1 h at 669 37 °C and 5% CO 2 . Immunoblotting was performed with the anti-puromycin antibody The authors declare no competing interests. Advancing host-directed therapy for tuberculosis The IL-13/IL-4Ralpha axis is involved in tuberculosis-associated pathology Tumor-associated macrophages as major 721 players in the tumor microenvironment Macrophage plasticity and polarization: in vivo veritas Preexisting 725 helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by 726 engaging the IL-4 receptor pathway Effect of helminth-induced immunity on infections 728 with microbial pathogens T helper 2 730 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. 731 Immunity Anti-IFN-gamma 733 autoantibodies in disseminated nontuberculous mycobacterial infections Anticytokine autoantibodies in infectious diseases: 736 pathogenesis and mechanisms Repression of IL-4-738 induced gene expression by IFN-gamma requires Stat1 activation Heterogeneity in tuberculosis Spatial and 743 temporal localization of immune transcripts defines hallmarks and diversity in the 744 tuberculosis granuloma Macrophage polarization drives granuloma outcome during Mycobacterium tuberculosis 747 infection Defining features of protective CD4 T cell 749 responses to Mycobacterium tuberculosis Fine-tuning of macrophage activation using synthetic rocaglate derivatives Tight 754 coordination of protein translation and HSF1 activation supports the anabolic malignant 755 state Silvestrol and 757 episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris Silvestrol, a potential 760 anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells 761 through the mitochondrial/apoptosome pathway without activation of executioner 762 caspase-3 or -7 Potential of 764 cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and 768 picornaviruses Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse 771 lymphoma model The natural 773 anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting 774 prohibitin 1 and 2 Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation 777 Inhibitors: Synthetic and Biological Studies p62/SQSTM1 functions as a signaling hub 780 and an autophagy adaptor Feedback on fat: p62-mTORC1-autophagy connections Fighting disease by selective autophagy of aggregate-784 prone proteins Selective autophagy mediated by autophagic adapter proteins Molecular mechanisms of the Keap1-Nrf2 788 pathway in stress response and cancer evolution The emerging role of the Nrf2-Keap1 signaling pathway 790 in cancer Structural basis for defects of Keap1 activity provoked by its point mutations in lung 793 cancer Kinetic, 795 thermodynamic, and structural characterizations of the association between Nrf2-DLGex 796 degron and Keap1 The 798 selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 799 through inactivation of Keap1 A noncanonical 801 mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 802 and p62 Targeted 804 disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the 805 JAK-STAT signaling pathway GAS elements: a few nucleotides with a major 807 impact on cytokine-induced gene expression The STATs in cell stress-type responses Maximal activation of transcription by Stat1 and 812 Stat3 requires both tyrosine and serine phosphorylation Goh KC, Haque SJ, and Williams BR. p38 MAP kinase is required for STAT1 serine 816 phosphorylation and transcriptional activation induced by interferons Macrophages and c-Myc cross paths Role of c-820 MYC in alternative activation of human macrophages and tumor-associated macrophage 821 biology RNA G-823 quadruplexes cause eIF4A-dependent oncogene translation in cancer Interactions between autophagy receptors 826 and ubiquitin-like proteins form the molecular basis for selective autophagy The adaptor 829 protein p62/SQSTM1 targets invading bacteria to the autophagy pathway Measurement of Macrophage 832 Growth and Differentiation. Current protocols in immunology Akt Signaling Pathway 835 in Macrophage Activation and M1/M2 Polarization Microenvironments in Tuberculous Granulomas Are Delineated by Distinct Populations 839 of Macrophage Subsets and Expression of Nitric Oxide Synthase and Arginase Isoforms Female 842 resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a 843 therapeutic target Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving 846 model of pulmonary infection Intracellular trafficking and 848 killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by 849 opsonins Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. 852 PLoS One Rocaglates convert DEAD-box protein eIF4A into 854 a sequence-selective translational repressor The 856 Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity Ras/Erk pathway positively regulates 859 Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the 863 RNA Helicase, eIF4A Hormesis: why it is important to toxicology and toxicologists. Environ 865 Toxicol Chem Rocaglates as 867 dual-targeting agents for experimental cerebral malaria. Proceedings of the National 868 Academy of Sciences of the United States of America 870 Translational profiling of macrophages infected with Leishmania donovani identifies 871 mTOR-and eIF4A-sensitive immune-related transcripts Natural antiviral 874 compound silvestrol modulates human monocyte derived macrophages and dendritic 875 cells A SARS-CoV-877 2 protein interaction map reveals targets for drug repurposing HIV and TB increase death risk from COVID-19, study finds-but not by 879 much Myeloid cells in the tumor microenvironment: modulation 881 of tumor angiogenesis and tumor inflammation Nonresolving macrophage mediated inflammation in malignancy Nontuberculous Mycobacterial Infection as a Cause of Difficult-to-Control Asthma: A 888 Case-Control Study Dual-promoter 890 lentiviral system allows inducible expression of noxious proteins in macrophages SUnSET, a nonradioactive method to 893 monitor protein synthesis